Share this video  

ASCO GI 2021 | Landscape of actionable somatic alterations in advanced CCA

Pashtoon M. Kasi, MD, MS, University of Iowa, Iowa City, IA, discusses the results of an investigation aiming to characterize genomic alterations that are linked to targeted therapies to facilitate a personalized approach to the treatment and management of cholangiocarcinoma (CCA). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).